Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 35

Breast Cancer Biomarker Panel: ER, PR, HER2, Ki-67, Genomic Tests, and...

Breast cancer gene panel testing explained: BRCA1/2, PALB2, CHEK2, ATM, positive and VUS results, hereditary risk, screening, and family testing.

Breast Cancer Gene Panel Test: BRCA, PALB2, CHEK2, ATM, and Hereditary...

Breast Cancer Index explained: late distant-recurrence risk, BCI H/I High or Low results, extended hormone therapy benefit, limits, and next steps.

Breast Cancer Index Test: Late Recurrence Risk and Hormone Therapy Benefit...

CA 15-3 breast cancer testing explained: reference range, high and normal results, serial trends, metastatic monitoring, recurrence limits, and follow-up guidance.

CA 15-3 Test for Breast Cancer: Tumor Marker Levels, Monitoring, and...

CA 27.29 breast cancer testing explained: reference range, high and normal results, serial trends, metastatic monitoring, recurrence limits, and follow-up guidance.

CA 27.29 Test for Breast Cancer: Tumor Marker Levels, Monitoring, and...

Breast cancer ctDNA testing explained: MRD, recurrence risk, mutation detection, liquid biopsy, treatment selection, false negatives, and current monitoring guidance.

Circulating Tumor DNA Test for Breast Cancer: MRD, Recurrence, Mutation Detection,...

EndoPredict explained: EP and EPclin scores, the 3.3 cutoff, distant recurrence risk, genomic prognosis, chemotherapy decisions, and test limitations.

EndoPredict Test: Breast Cancer Recurrence Risk and Genomic Prognosis

ESR1 mutation testing explained: hormone resistance, ctDNA detection, positive and negative results, oral SERDs, recurrence limits, and 2026 treatment guidance.

ESR1 Mutation Test for Breast Cancer: Hormone Resistance Marker, Recurrence, and...

Learn how the estrogen receptor (ER) breast cancer test is scored, what ER-positive, ER-low, and ER-negative results mean, and how ER status guides treatment.

Estrogen Receptor (ER) Test: Breast Cancer Hormone Receptor Status, Positive Score,...

Understand HER2 breast cancer testing, including IHC scores, FISH amplification, positive and negative results, HER2-low, HER2-ultralow, and treatment meaning.

HER2 Breast Cancer Test: IHC, FISH, HER2 Score, Amplification, and HER2-Low...

Learn how the HER2 FISH test measures gene amplification, how HER2/CEP17 ratio and copy number define ISH groups, and what positive or negative results mean.

HER2 FISH Test for Breast Cancer: Gene Amplification, HER2 Status, and...

Learn how HER2 IHC scores 0, 1+, 2+, and 3+ are interpreted, what HER2-low and ultralow mean, when FISH is needed, and how results guide breast cancer therapy.

HER2 IHC Test for Breast Cancer: Protein Expression Score, HER2-Low, and...

Learn how HER2-low breast cancer is identified by IHC 1+ or IHC 2+/ISH-negative results, how scores are interpreted, and why HER2 expression can affect treatment.

HER2-Low Breast Cancer Test: IHC Score, HER2 Expression, and Tumor Classification

Hormone Receptor-Positive Breast Cancer Biomarker Panel: ER, PR, ESR1, PIK3CA, and...

Learn what a Ki-67 breast cancer score measures, how percentages relate to proliferation and tumor grade, which cutoffs are useful, and why results need clinical context.

Ki-67 Breast Cancer Test: Proliferation Score, Tumor Grade, and Prognosis Meaning

Learn how the MammaPrint 70-gene breast cancer test classifies genomic recurrence risk, what Low, High, and UltraLow results mean, and how it can inform chemotherapy decisions.

MammaPrint Test: Breast Cancer Recurrence Risk and Genomic Risk Score

1...343536...137 Page 35 of 137